Knowles Corp: Form 10-Q for the period ended Sep 30, 2023
Filed with the SEC on Nov 2, 2023 and accepted by EDGAR at Nov 2, 2023, 16:03 ET.
Management's discussion and analysis
As filed, 59,131 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following discussion and analysis should be read in conjunction with our Consolidated Financial Statements and related Notes included elsewhere in this Quarterly Report on Form 10-Q.
Overview
We are a market leader and global provider of advanced micro-acoustic microphones and balanced armature speakers, audio solutions, and high performance capacitors and radio frequency ("RF") filtering products, serving the medtech, defense, consumer electronics, electric vehicle, industrial, and communications markets. Our focus on the customer, combined with unique technology, proprietary manufacturing techniques, and global operational expertise, enables us to deliver innovative solutions across multiple applications. References to "Knowles," the "Company," "we," "our," or "us" refer to Knowles Corporation and its consolidated subsidiaries, unless the context otherwise requires.
During the fourth quarter of 2022, we determined each operating segment represents a single reportable segment; thus, we now report three segments. These segments were determined in accordance with Financial Accounting Standards Board Accounting Standards Codification 280 - Segment Reporting and are comprised of (i) Precision Devices ("PD"), (ii) MedTech & Specialty Audio ("MSA"), and (iii) Consumer MEMS Microphones ("CMM"). The segments are aligned around similar product applications serving our key end markets to enhance focus on end market growth strategies.
- PD Segment
Our PD segment specializes in the design and delivery of high performance capacitor products and RF solutions primarily serving the defense, medtech, industrial, communication, electric vehicle, and distribution markets. PD has sales, support, and engineering facilities in North America, Europe, and Asia as well as manufacturing facilities in North America and Asia.
- MSA Segment
Our MSA segment designs and manufactures microphones and balanced armature speakers used in applications that serve the hearing health and premium audio markets. MSA has sales, support, and engineering facilities in North America, Europe, and Asia, as well as manufacturing facilities in Asia.
- CMM Segment
Our CMM segment designs and manufactures micro-electro-mechanical systems ("MEMS") microphones and audio solutions used in applications that primarily serve the ear, Internet of Things ("IoT"), computing, and smartphone markets. CMM has sales, support, and engineering facilities in North America, Europe, and Asia, as well as manufacturing facilities in Asia.
We sell our products directly to original equipment manufacturers ("OEMs") and to their contract manufacturers and suppliers and through distributors worldwide.
On September 18, 2023, we announced that we are reviewing strategic alternatives for CMM. No assurance can be given that any transaction or other strategic outcomes will result from the review. We have not set a timetable for the conclusion of the strategic review and do not intend to comment on or provide updates regarding these matters unless and until we determine that further disclosure is appropriate or required.
Non-GAAP Financial Measures
In addition to the GAAP financial measures included in this item, we have presented certain non-GAAP financial measures. We use non-GAAP measures as supplements to our GAAP results of operations in evaluating certain aspects of our business, and our executive management team and Board of Directors focus on non-GAAP items as key measures of our performance for business planning purposes. These measures assist us in comparing our performance between various reporting periods on a consistent basis, as these measures remove from operating results the impact of items that, in our opinion, do not reflect our core operating performance. We believe that our presentation of non-GAAP financial measures is useful because it provides investors and securities analysts with the same information that we use internally for purposes of assessing our core operating performance. The Company does not consider these non-GAAP financial measures to be a substitute for the information provided by GAAP financial results. For a reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures, see the reconciliation included herein.
Results of Operations for the Three Months Ended September 30, 2023 compared with the Three Months Ended September 30, 2022
(in millions, except per share amounts)
| Three Months Ended September 30, 2023 | 2022 | |
|---|---|---|
| Revenues | $175.1 | $178.2 |
| Gross profit | $77.5 | $40.0 |
| Non-GAAP gross profit | $78.1 | $68.6 |
| Earnings (loss) before interest and income taxes | $22.1 | $(12.5) |
| Adjusted earnings before interest and income taxes | $36.8 | $28.2 |
| Provision for (benefit from) income taxes | $4.9 | $(16.3) |
| Non-GAAP provision for income taxes | $6.9 | $3.8 |
| Net earnings | $16.6 | $2.7 |
| Non-GAAP net earnings | $29.3 | $23.3 |
| Diluted earnings per share | $0.18 | $0.03 |
| Non-GAAP diluted earnings per share | $0.31 | $0.25 |
Revenues
Revenues for the third quarter of 2023 were $175.1 million, compared with $178.2 million for the third quarter of 2022, a decrease of $3.1 million or 1.7%. PD revenues decreased $14.2 million, primarily due to lower demand from the industrial, communication, defense, medtech, and distribution markets as a result of continued demand weakness associated with excess channel inventory and timing of shipments into the defense market. MSA revenues increased $9.5 million, primarily due to higher shipping volumes into the hearing health and premium audio markets as demand has returned to normalized levels. CMM revenues increased $1.6 million, primarily due to higher demand in the computing and IoT markets, partially offset by lower average pricing on mature products.
Cost of Goods Sold
Cost of goods sold ("COGS") for the third quarter of 2023 was $102.7 million, compared with $110.1 million for the third quarter of 2022, a decrease of $7.4 million or 6.7%. This decrease was primarily due to product cost reductions, benefits of prior year restructuring actions, favorable product mix, favorable foreign currency changes, partially offset by lower factory capacity utilization and higher shipping volumes.
Gain on Sale of Fixed Assets
As a result of transitioning to our next generation of MEMS wafer manufacturing technology, we sold certain machinery and equipment related to the CMM segment in the third quarter of 2023 and recorded a gain of $5.2 million. For additional information, refer to Note 6. Property, Plant, and Equipment, net to our Consolidated Financial Statements.
Restructuring Charges
During the third quarter of 2023, we recorded restructuring charges of $1.3 million for severance pay and benefits related to headcount reductions within our PD segment and $0.4 million in other charges, all primarily in Operating expenses. We also recorded a $0.1 million gain on the sale of certain machinery and equipment that was previously written off through restructuring charges in Gross profit and the CMM Segment. For additional information, refer to Note 8. Restructuring and Related Activities to our Consolidated Financial Statements.
During the third quarter of 2022, we committed to a restructuring program within our CMM segment designed to rightsize manufacturing capacity and operating expenses in the MEMS microphones product line. This action was taken in light of the decline in demand and the reduction in the expected future growth for global consumer electronics. In addition, this restructuring program furthers the Company's previously announced strategy to reduce exposure to commodity microphones and increase emphasis on high-value solutions. This action resulted in the settlement of supplier obligations, non-cash fixed asset write-offs, and severance pay. We recorded restructuring charges of $29.8 million related to this action. In addition, we recorded restructuring charges of $1.0 million related to headcount reductions within the Intelligent Audio product line workforce, which is also included within the Audio segment. As a result, we recorded total restructuring charges of $28.1 million within Gross Profit and $2.7 million within Operating expenses. For additional information, refer to Note 8. Restructuring and Related Activities to our Consolidated Financial Statements.
Gross Profit and Non-GAAP Gross Profit
Gross profit for the third quarter of 2023 was $77.5 million, compared with $40.0 million for the third quarter of 2022, an increase of $37.5 million or 93.8%. Gross profit margin (gross profit as a percentage of revenues) for the third quarter of 2023 was 44.3%, compared with 22.4% for the third quarter of 2022. The increases were primarily due to lower restructuring charges, product cost reductions, the gain on sale of fixed assets, benefits of prior year restructuring, favorable product mix, and favorable foreign currency exchange rate changes, partially offset by lower average pricing on mature products shipped into the mobile market and lower factory capacity utilization.
Non-GAAP gross profit for the third quarter of 2023 was $78.1 million, compared with $68.6 million for the third quarter of 2022, an increase of $9.5 million or 13.8%. Non-GAAP gross profit margin (non-GAAP gross profit as a percentage of revenues) for the third quarter of 2023 was 44.6%, compared with 38.5% for the third quarter of 2022. The increases in non-GAAP gross profit were primarily due to product cost reductions, the gain on sale of fixed assets, benefits of prior year restructuring, favorable product mix, and favorable foreign currency exchange rate changes, partially offset by lower average pricing on mature products shipped into the mobile market and lower factory capacity utilization.
Research and Development Expenses
Research and development expenses for the third quarter of 2023 were $19.8 million, compared with $19.3 million for the third quarter of 2022, an increase of $0.5 million or 2.6%. Research and development expenses as a percentage of revenues for the third quarter of 2023 and 2022 were 11.3% and 10.8%, respectively. The increase in expenses was primarily driven by increased development activities in our MSA segment, partially offset by reduced spending in our CMM segment driven by the benefits of prior year restructuring actions as we continue to shift our focus and spending to our higher margin businesses. The increase in expenses as a percentage of revenues was driven by our lower revenues.
Selling and Administrative Expenses
Selling and administrative expenses for the third quarter of 2023 were $34.6 million, compared with $32.6 million for the third quarter of 2022, an increase of $2.0 million or 6.1%. Selling and administrative expenses as a percentage of revenues for the third quarter of 2023 and 2022 were 19.8% and 18.3%, respectively. The increase in expenses was primarily driven by higher professional service fees. The increase in expenses as a percentage of revenues was driven by our increase in expenses and lower revenues.
Interest Expense, net
Interest expense for the third quarter of 2023 and 2022 was $0.6 million, compared with $1.1 million for the third quarter of 2022, a decrease of $0.5 million. We had a lower outstanding revolving credit facility balance during the third quarter of 2023 compared to the third quarter of 2022, offset by higher interest rates. For additional information on borrowings and interest expense, refer to Note 9. Borrowings to our Consolidated Financial Statements.
Other Income, net
Other income for the third quarter of 2023 was $0.5 million, compared with income of $2.1 million for the third quarter of 2022, a change of $1.6 million. The change is primarily due to less favorable foreign currency exchange rate changes.
Provision for Income Taxes and Non-GAAP Provision for Income Taxes
The effective tax rate ("ETR") for the third quarter of 2023 and 2022 was 22.8% and 119.9%, respectively. The ETR for the third quarter of 2023 includes discrete items totaling $0.8 million of tax benefit primarily attributable to stock-based compensation and the recognition of foreign tax credits resulting from the release of IRS Notice 2023-55. Absent the discrete items, the ETR for the third quarter of 2023 and 2022 was 26.5% and 119.9%, respectively. The Company accrues taxes in various countries where it generates income and applies a valuation allowance in other jurisdictions, which resulted in the provision (benefit) for the third quarter of 2023 and 2022, respectively. The change in the ETR was mainly due to the book goodwill impairment recorded in the second quarter of 2022, as well as the mix of earnings and losses by taxing jurisdictions and net discrete items.
The non-GAAP ETR for the third quarter of 2023 and 2022 was 19.1% and 14.0%, respectively. The non-GAAP ETR for the third quarter of 2023 was impacted by a net discrete expense totaling $0.1 million. Absent the discrete items, the non-GAAP ETR for the third quarter of 2023 and 2022 was 18.8% and 14.0%, respectively. The change in the non-GAAP ETR was primarily due to lower pre-tax earnings and the loss of our Malaysian tax holiday.
The ETR and non-GAAP ETR deviate from the statutory U.S. federal income tax rate, mainly due to the taxing jurisdictions where we generate taxable income or loss. As a result of the rapid decline in demand for global consumer electronics during 2022, we did not satisfy all of the conditions of our tax holiday in Malaysia. As such, we are not including this tax holiday benefit in our 2023 GAAP ETR and non-GAAP ETR. For additional information on tax holidays refer to Note 11. Income Taxes to our Consolidated Financial Statements.
Net Earnings
Net earnings for the third quarter of 2023 were $16.6 million, compared with $2.7 million for the third quarter of 2022, an increase of $13.9 million. As described above, the increase is primarily due to higher gross profit, partially offset by higher income tax expense.
Earnings (Loss) and Adjusted Earnings Before Interest and Income Taxes
Earnings before interest and income taxes ("EBIT") for the third quarter of 2023 was $22.1 million, compared with a $12.5 million loss for the third quarter of 2022, an increase of $34.6 million. EBIT margin (EBIT as a percentage of revenues) for the third quarter of 2023 was 12.6%, compared with (7.0)% for the third quarter of 2022. The change is primarily due to higher gross profit.
Adjusted earnings before interest and income taxes ("Adjusted EBIT") for the third quarter of 2023 was $36.8 million, compared with $28.2 million for the third quarter of 2022, an increase of $8.6 million. Adjusted EBIT margin (Adjusted EBIT as a percentage of revenues) for the third quarter of 2023 was 21.0%, compared with 15.8% for the third quarter of 2022. The increases were primarily due to higher non-GAAP gross profit.
Diluted Earnings per Share and Non-GAAP Diluted Earnings per Share
Diluted earnings per share was $0.18 for the third quarter of 2023, compared with earnings per share of $0.03 for the third quarter of 2022, an increase of $0.15. As described above, the increase is primarily due to higher gross profit, partially offset by higher income tax expense.
Non-GAAP diluted earnings per share was $0.31 for the third quarter of 2023, compared with $0.25 for the third quarter of 2022, an increase of $0.06. As described above, the increase was primarily due to higher non-GAAP gross profit partially offset by higher non-GAAP income tax expenses.
Results of Operations for the Nine Months Ended September 30, 2023 compared with the Nine Months Ended September 30, 2022
(in millions, except per share amounts)
| Nine Months Ended September 30, 2023 | 2022 | |
|---|---|---|
| Revenues | $492.4 | $567.6 |
| Gross profit | $205.0 | $201.0 |
| Non-GAAP gross profit | $205.2 | $230.5 |
| Earnings (loss) before interest and income taxes | $37.0 | $(207.0) |
| Adjusted earnings before interest and income taxes | $72.6 | $105.2 |
| Provision for income taxes | $9.8 | $12.4 |
| Non-GAAP provision for income taxes | $14.1 | $13.9 |
| Net earnings (loss) | $25.0 | $(222.1) |
| Non-GAAP net earnings | $56.3 | $88.6 |
| Diluted earnings (loss) per share | $0.27 | $(2.42) |
| Non-GAAP diluted earnings per share | $0.60 | $0.93 |
Revenues
Revenues for the nine months ended September 30, 2023 were $492.4 million, compared with $567.6 million for the nine months ended September 30, 2022, a decrease of $75.2 million or 13.2%. PD revenues decreased $27.9 million, primarily due to lower demand from the industrial, communication, distribution, defense, and medtech markets as a result of continued demand weakness associated with excess channel inventory and timing of shipments into the defense market. CMM revenues decreased $41.8 million, primarily due to lower demand for MEMS microphones in the mobile and IoT markets. The decreases in these markets were primarily driven by weak global demand for consumer electronics and excess inventory in the supply chain. In addition to lower end market demand, shipping volumes were unfavorably impacted earlier this year by financial incentives offered to customers resulting in higher shipping volumes in the fourth quarter of 2022. CMM revenues were also impacted by lower average pricing on mature products shipped into the mobile market. MSA revenues decreased $5.5 million, primarily due to lower shipping volumes into the hearing health market as customers reduced their inventory levels, partially offset by higher shipping volumes into the premium audio market. In addition to lower end market demand, shipping volumes were unfavorably impacted earlier this year by financial incentives offered to customers resulting in higher shipping volumes in the fourth quarter of 2022.
Cost of Goods Sold
COGS for the nine months ended September 30, 2023 was $298.9 million, compared with $338.5 million for the nine months ended September 30, 2022, a decrease of $39.6 million or 11.7%. This decrease was primarily due to lower shipping volumes, product cost reductions, benefits of prior year restructuring actions, and favorable foreign currency exchange rate changes, partially offset by lower factory capacity utilization.
Gain on Sale of Fixed Assets
As a result of transitioning to our next generation of MEMS wafer manufacturing technology, we sold certain machinery and equipment related to the CMM segment in the nine months ended September 30, 2023 and recorded a gain of $10.0 million. For additional information, refer to Note 6. Property, Plant, and Equipment, net to our Consolidated Financial Statements.
Restructuring Charges
During the nine months ended September 30, 2023, we recorded a $1.0 million gain on the sale of certain machinery and equipment that was previously written off through restructuring charges and a $0.8 million reversal of restructuring charges related to a change in estimate, all within Gross profit and the CMM Segment. We also recorded restructuring charges in Operating expenses of $1.4 million for severance pay and benefits related to headcount reductions within our CMM segment, $1.3 million for severance pay and benefits related to headcount reductions within our PD segment, and $0.7 million for other costs. For additional information, refer to Note 8. Restructuring and Related Activities to our Consolidated Financial Statements.
During the nine months ended September 30, 2022, we committed to a restructuring program within our CMM segment designed to rightsize manufacturing capacity and operating expenses in the MEMS microphones product line, designed to rightsize manufacturing capacity and operating expenses in the MEMS microphones product line. These actions were taken in light of the current decline in demand and the reduction in the expected future growth for global consumer electronics. In addition, these restructuring programs further the Company's previously announced strategy to reduce exposure to commodity microphones and increase emphasis on high-value solutions. These actions resulted in the settlement of supplier obligations, non-cash fixed asset write-offs, and severance pay. We recorded restructuring charges of $35.1 million related to these actions and $0.6 million for other costs. In addition, we recorded restructuring charges of $2.2 million related to headcount reductions within the Intelligent Audio product line workforce, which is also included within the CMM segment. As a result, we recorded total restructuring charges of $28.1 million within Gross Profit and $9.8 million within Operating expenses. For additional information, refer to Note 8. Restructuring and Related Activities to our Consolidated Financial Statements.
Gross Profit and Non-GAAP Gross Profit
Gross profit for the nine months ended September 30, 2023 was $205.0 million, compared with $201.0 million for the nine months ended September 30, 2022, an increase of $4.0 million or 2.0%. Gross profit margin for the nine months ended September 30, 2023 was 41.6%, compared with 35.4% for the nine months ended September 30, 2022. The increase in gross profit was primarily due to lower restructuring charges, product cost reductions, benefits of prior year restructuring actions, the gain on sale of fixed assets, and favorable foreign currency exchange rate changes, partially offset by lower shipping volumes, factory capacity utilization, and lower average pricing on mature products shipped into the mobile market. The increase in gross profit margin was primarily due to lower restructuring charges, product cost reductions, benefits of prior year restructuring actions, the gain on sale of fixed assets, and favorable foreign currency exchange rate changes, partially offset by lower factory capacity utilization and average pricing on mature products shipped into the mobile market.
Non-GAAP gross profit for the nine months ended September 30, 2023 was $205.2 million, compared with $230.5 million for the nine months ended September 30, 2022, a decrease of $25.3 million or 11.0%. Non-GAAP gross profit margin for the nine months ended September 30, 2023 was 41.7%, compared with 40.6% for the nine months ended September 30, 2022. The decrease in non-GAAP gross profit was primarily due to lower shipping volumes, factory capacity utilization, and lower average pricing on mature products shipped into the mobile market, partially offset by product cost reductions, benefits of prior year restructuring actions, the gain on sale of fixed assets, and favorable foreign currency exchange rate changes. The increase in non-GAAP gross profit margin was primarily due to product cost reductions, benefits of prior year restructuring actions, the gain on sale of fixed assets, and favorable foreign currency exchange rate changes, partially offset by lower factory capacity utilization and lower average pricing on mature products shipped into the mobile market.
Research and Development Expenses
Research and development expenses for the nine months ended September 30, 2023 were $59.5 million, compared with $63.7 million for the nine months ended September 30, 2022, a decrease of $4.2 million or 6.6%. Research and development expenses as a percentage of revenues for the nine months ended September 30, 2023 and 2022 were 12.1% and 11.2%, respectively. The decrease in expenses was primarily driven by reduced spending in our CMM segment driven by the benefits of prior year restructuring actions, partially offset by increased development activities in our MSA and PD segments as we continue to shift our focus and spending to our higher margin businesses. The increase in expenses as a percentage of revenues was driven by our lower revenues.
Selling and Administrative Expenses
Selling and administrative expenses for the nine months ended September 30, 2023 were $104.9 million, compared with $95.6 million for the nine months ended September 30, 2022, an increase of $9.3 million or 9.7%. Selling and administrative expenses as a percentage of revenues for the nine months ended September 30, 2023 and 2022 were 21.3% and 16.8%, respectively. The increase in expenses was primarily driven by higher professional service fees. The increase in expenses as a percentage of revenues was driven by our lower revenues and an increase in expenses.
Impairment Charges
No impairment charges were recorded during the nine months ended September 30, 2023. Impairment charges for the nine months ended September 30, 2022 were $239.8 million related to a goodwill impairment charge for the MCE reporting unit. For additional information related to these impairment charges, refer to Note 4. Impairment Charges to our Consolidated Financial Statements.
Interest Expense, net
Interest expense for the nine months ended September 30, 2023 and 2022 was $2.2 million, compared with $2.7 million for the nine months ended September 30, 2022, a decrease of $0.5 million. We had a lower outstanding revolving credit facility balance during the nine months ended September 30, 2023 compared to the nine months ended September 30, 2022, offset by higher interest rates. For additional information on borrowings and interest expense, refer to Note 9. Borrowings to our Consolidated Financial Statements.
Other Expense (Income), net
Other expense for the nine months ended September 30, 2023 was $0.5 million, compared with income of $0.9 million for the nine months ended September 30, 2022, a change of $1.4 million. Expense in 2023 represents unfavorable foreign currency exchange rate impacts, partially offset by the unrealized gains in our investment balances. Income in 2022 represents favorable impacts from foreign currency exchange rate changes, partially offset by an adjustment to pre-spin-off pension obligations and the depreciation in our investment balances.
Provision for Income Taxes and Non-GAAP Provision for Income Taxes
The ETR for the nine months ended September 30, 2023 and 2022 was 28.2% and (5.9)%, respectively. The ETR for the nine months ended September 30, 2023 and 2022 includes discrete items totaling $0.1 million and $1.6 million of tax benefit, respectively. The discrete items impacting the tax provision for the nine months ended September 30, 2023 are primarily attributable to stock-based compensation and the recognition of foreign tax credits resulting from the release of IRS Notice 2023-55. The discrete items impacting the tax provision for the nine months ended September 30, 2022 are primarily attributable to stock-based compensation. Absent the discrete items, the ETR for the nine months ended September 30, 2023 and 2022 was 28.4% and (6.7)%, respectively. The Company accrues taxes in various countries where it generates income and applies a valuation allowance in other jurisdictions, which resulted in the provision for both the nine months ended September 30, 2023 and 2022. The change in the ETR was mainly due to the book goodwill impairment recorded in the second quarter of 2022, as well as the mix of earnings and losses by taxing jurisdictions and net discrete items.
The non-GAAP ETR for the nine months ended September 30, 2023 and 2022 was 20.0% and 13.6%, respectively. The non-GAAP ETR includes discrete items totaling $1.0 million of tax expense for the nine months ended September 30, 2023 and a net discrete benefit totaling $0.4 million for the nine months ended September 30, 2022. Absent the discrete items, the non-GAAP ETR for the nine months ended September 30, 2023 and 2022 was 18.6% and 14.0%, respectively. The change in the non-GAAP ETR was primarily due to lower pre-tax earnings and the loss of our Malaysian tax holiday.
The ETR and non-GAAP ETR deviate from the statutory U.S. federal income tax rate, mainly due to the taxing jurisdictions where we generate taxable income or loss. As a result of the rapid decline in demand for global consumer electronics during 2022, we did not satisfy all of the conditions of our tax holiday in Malaysia. As such, we are not including this tax holiday benefit in our 2023 GAAP ETR and non-GAAP ETR. For additional information on tax holidays refer to Note 11. Income Taxes to our Consolidated Financial Statements.
Net Earnings (Loss)
Net earnings for the nine months ended September 30, 2023 was $25.0 million, compared with a loss of $222.1 million for the nine months ended September 30, 2022, an increase of $247.1 million. As described above, the increase is primarily due to impairment charges in 2022 that did not recur in 2023, higher gross profit, and lower income tax expense.
Earnings (Loss) and Adjusted Earnings Before Interest and Income Taxes
EBIT for the nine months ended September 30, 2023 was $37.0 million, compared with a loss of $207.0 million for the nine months ended September 30, 2022, an increase of $244.0 million. EBIT margin for the nine months ended September 30, 2023 was 7.5%, compared with (36.5)% for the nine months ended September 30, 2022. The change is primarily due to impairment charges recorded in 2022 that did not recur in 2023 and higher gross profit.
Adjusted earnings before interest and income taxes for the nine months ended September 30, 2023 was $72.6 million, compared with $105.2 million for the nine months ended September 30, 2022, a decrease of $32.6 million. Adjusted EBIT margin for the nine months ended September 30, 2023 was 14.7%, compared with 18.5% for the nine months ended September 30, 2022. The decreases were primarily due to lower non-GAAP gross profit.
Diluted Earnings (Loss) per Share and Non-GAAP Diluted Earnings per Share
Diluted earnings per share was $0.27 for the nine months ended September 30, 2023, compared with a loss per share of $2.42 for the nine months ended September 30, 2022, an increase of $2.69. As described above, the change is primarily due to impairment charges recorded in 2022 that did not recur in 2023 and higher gross profit.
Non-GAAP diluted earnings per share was $0.60 for the nine months ended September 30, 2023, compared with $0.93 for the nine months ended September 30, 2022, a decrease of $0.33. As described above, the decrease was primarily due to lower non-GAAP gross profit.
Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures (1)
(in millions, except per share amounts)
| Three Months Ended September 30, 2023 | 2022 | Nine Months Ended September 30, 2023 | 2022 | |
|---|---|---|---|---|
| Gross profit | $77.5 | $40.0 | $205.0 | $201.0 |
| Stock-based compensation expense | 0.5 | 0.5 | 1.7 | 1.4 |
| Restructuring charges | 0.1 | 28.1 | (1.5) | 28.1 |
| Non-GAAP gross profit | $78.1 | $68.6 | $205.2 | $230.5 |
| Net earnings (loss) | $16.6 | $2.7 | $25.0 | $(222.1) |
| Interest expense, net | 0.6 | 1.1 | 2.2 | 2.7 |
| Provision for (benefit from) income taxes | 4.9 | (16.3) | 9.8 | 12.4 |
| Earnings (loss) before interest and income taxes | 22.1 | (12.5) | 37.0 | (207.0) |
| Stock-based compensation expense | 6.9 | 6.8 | 21.8 | 21.6 |
| Intangibles amortization expense | 3.0 | 3.1 | 8.8 | 9.2 |
| Impairment charges | — | — | — | 239.8 |
| Restructuring charges | 1.6 | 30.8 | 1.6 | 37.9 |
| Acquisition-related costs (2) | 3.0 | — | 3.0 | — |
| Other (3) | 0.2 | — | 0.4 | 3.7 |
| Adjusted earnings before interest and income taxes | $36.8 | $28.2 | $72.6 | $105.2 |
| Provision for (benefit from) income taxes | $4.9 | $(16.3) | $9.8 | $12.4 |
| Income tax effects of non-GAAP reconciling adjustments (4) | 2.0 | 20.1 | 4.3 | 1.5 |
| Non-GAAP provision for income taxes | $6.9 | $3.8 | $14.1 | $13.9 |
| Net earnings (loss) | $16.6 | $2.7 | $25.0 | $(222.1) |
| Non-GAAP reconciling adjustments (5) | 14.7 | 40.7 | 35.6 | 312.2 |
| Income tax effects of non-GAAP reconciling adjustments (4) | 2.0 | 20.1 | 4.3 | 1.5 |
| Non-GAAP net earnings | $29.3 | $23.3 | $56.3 | $88.6 |
| Diluted earnings (loss) per share | $0.18 | $0.03 | $0.27 | $(2.42) |
| Earnings per share non-GAAP reconciling adjustment | 0.13 | 0.22 | 0.33 | 3.35 |
| Non-GAAP diluted earnings per share | $0.31 | $0.25 | $0.60 | $0.93 |
| Diluted average shares outstanding | 91.4 | 92.0 | 91.9 | 91.9 |
| Non-GAAP adjustment (6) | 2.6 | 2.2 | 2.5 | 3.2 |
| Non-GAAP diluted average shares outstanding (6) | 94.0 | 94.2 | 94.4 | 95.1 |
29
(1) In addition to the GAAP financial measures included herein, Knowles has presented certain non-GAAP financial measures that exclude certain amounts that are included in the most directly comparable GAAP measures. Knowles believes that non-GAAP measures are useful as supplements to its GAAP results of operations to evaluate certain aspects of its operations and financial performance, and its management team primarily focuses on non-GAAP items in evaluating Knowles' performance for business planning purposes. Knowles also believes that these measures assist it with comparing its performance between various reporting periods on a consistent basis, as these measures remove from operating results the impact of items that, in Knowles' opinion, do not reflect its core operating performance. Knowles believes that its presentation of non-GAAP financial measures is useful because it provides investors and securities analysts with the same information that Knowles uses internally for purposes of assessing its core operating performance.
(2) These expenses are related to the acquisition of Cornell Dubilier by the Precision Devices segment.
(3) In 2023, Other expenses include non-recurring professional service fees related to an evaluation of a reorganization. In addition, Other expenses include the ongoing net lease cost (income) related to facilities not used in operations. In 2022, Other expenses represent an adjustment to pre-spin-off pension obligations of $3.4 million, which was recorded during the second quarter of 2022 in Other expense (income), net line on the Consolidated Statements of Earnings, and the ongoing net lease cost related to facilities not used in operations.
(4) Income tax effects of non-GAAP reconciling adjustments are calculated using the applicable tax rates in the jurisdictions of the underlying adjustments.
(5) The non-GAAP reconciling adjustments are those adjustments made to reconcile Earnings (loss) before interest and income taxes to Adjusted earnings before interest and income taxes.
(6) The number of shares used in the diluted per share calculations on a non-GAAP basis excludes the impact of stock-based compensation expense expected to be incurred in future periods and not yet recognized in the financial statements, which would otherwise be assumed to be used to repurchase shares under the GAAP treasury stock method.
Segment Results of Operations for the Three Months Ended September 30, 2023 compared with the Three Months Ended September 30, 2022
The following is a summary of the results of operations of our three reportable segments: Precision Devices, Medtech & Specialty Audio, and Consumer MEMS Microphones.
See Note 15. Segment Information to the Consolidated Financial Statements for (i) a reconciliation of segment revenues to our consolidated revenues and (ii) a reconciliation of segment earnings before interest and income taxes to our consolidated earnings.
Precision Devices
(in millions)
| Three Months Ended September 30, 2023 | Percent of Revenues | 2022 | Percent of Revenues | |
|---|---|---|---|---|
| Revenues | $50.2 | $64.4 | ||
| Earnings before interest and income taxes | $6.1 | 12.2% | $16.2 | 25.2% |
| Stock-based compensation expense | 0.8 | 0.6 | ||
| Intangibles amortization expense | 1.5 | 1.5 | ||
| Restructuring charges | 1.3 | — | ||
| Adjusted earnings before interest and income taxes | $9.7 | 19.3% | $18.3 | 28.4% |
Revenues
PD revenues were $50.2 million for the third quarter of 2023, compared with $64.4 million for the third quarter of 2022, a decrease of $14.2 million or 22.0%. Revenues decreased primarily due to lower demand from the industrial, communication, defense, medtech, and distribution markets as a result of continued demand weakness associated with excess channel inventory and timing of shipments into the defense market.
Earnings and Adjusted Earnings Before Interest and Income Taxes
PD EBIT was $6.1 million for the third quarter of 2023, compared with $16.2 million for the third quarter of 2022, a decrease of $10.1 million. EBIT margin for the third quarter of 2023 was 12.2%, compared to 25.2% for the third quarter of 2022. The decreases were primarily due to lower revenues and lower gross profit margin, partially offset by lower operating expenses. The gross profit margin decrease was primarily driven lower factory capacity utilization.
PD Adjusted EBIT was $9.7 million for the third quarter of 2023, compared with $18.3 million for the third quarter of 2022, a decrease of $8.6 million. Adjusted EBIT margin for the third quarter of 2023 was 19.3%, compared with 28.4% for the third quarter of 2022. The decreases were primarily due to lower revenues and lower non-GAAP gross profit margin. The non-GAAP gross profit margin decrease was primarily driven by lower factory capacity utilization.
MedTech & Specialty Audio
(in millions)
| Three Months Ended September 30, 2023 | Percent of Revenues | 2022 | Percent of Revenues | |
|---|---|---|---|---|
| Revenues | $56.5 | $47.0 | ||
| Earnings before interest and income taxes | $22.2 | 39.3% | $15.4 | 32.8% |
| Stock-based compensation expense | 0.9 | 0.7 | ||
| Adjusted earnings before interest and income taxes | $23.1 | 40.9% | $16.1 | 34.3% |
Revenues
MSA revenues were $56.5 million for the third quarter of 2023, compared with $47.0 million for the third quarter of 2022, an increase of $9.5 million or 20.2%. Revenues increased primarily due to higher shipping volumes into the hearing health and premium audio markets as demand has returned to normalized levels compared to the third quarter of 2022.
Earnings and Adjusted Earnings Before Interest and Income Taxes
MSA EBIT was $22.2 million for the third quarter of 2023, compared with $15.4 million for the third quarter of 2022, an increase of $6.8 million or 44.2%. EBIT margin for the third quarter of 2023 was 39.3%, compared with 32.8% for the third quarter of 2022. The increases were primarily due to higher revenues and gross profit margins, partially offset by higher operating expenses. The higher gross profit margin was driven by product cost reductions, favorable foreign currency exchange rates, and product mix.
MSA Adjusted EBIT was $23.1 million for the third quarter of 2023, compared with $16.1 million for the third quarter of 2022, an increase of $7.0 million. Adjusted EBIT margin for the third quarter of 2023 was 40.9%, compared to 34.3% for the third quarter of 2022. The increases were primarily due to higher revenues and non-GAAP gross profit margins, partially offset by higher non-GAAP operating expenses. The higher non-GAAP gross profit margin was driven by product cost reductions, favorable foreign currency exchange rates, and product mix.
Consumer MEMS Microphones
(in millions)
| Three Months Ended September 30, 2023 | Percent of Revenues | 2022 | Percent of Revenues | |
|---|---|---|---|---|
| Revenues | $68.4 | $66.8 | ||
| Earnings (loss) before interest and income taxes | $11.1 | 16.2% | $(32.3) | (48.4)% |
| Stock-based compensation expense | 1.2 | 1.3 | ||
| Intangibles amortization expense | 1.5 | 1.6 | ||
| Restructuring charges | (0.1) | 30.7 | ||
| Other (1) | (0.6) | — | ||
| Adjusted earnings before interest and income taxes | $13.1 | 19.2% | $1.3 | 1.9% |
| (1) Other represents the ongoing net lease cost related to facilities not used in operations. |
Revenues
CMM revenues were $68.4 million for the third quarter of 2023, compared with $66.8 million for the third quarter of 2022, an increase of $1.6 million or 2.4%. Revenues increased primarily due to higher demand in the computing and IoT markets, partially offset by lower average pricing on mature products.
Earnings (Loss) and Adjusted Earnings Before Interest and Income Taxes
CMM EBIT was $11.1 million for the third quarter of 2023, compared with a loss of $32.3 million for the third quarter of 2022, an increase of $43.4 million. The increase was primarily due to higher revenues, higher gross profit margins, and lower operating expenses. The higher gross profit margin was driven by lower restructuring charges, the gain on sale of fixed assets, product cost reductions, benefits of prior year restructuring actions, product mix, and increased factory capacity utilization, partially offset by lower average pricing on mature products shipped into the mobile market.
CMM Adjusted EBIT was $13.1 million for the third quarter of 2023, compared with $1.3 million for the third quarter of 2022, an increase of $11.8 million. Adjusted EBIT margin for the third quarter of 2023 was 19.2%, compared to 1.9% for the third quarter of 2022. The increases were primarily due to higher revenues, higher non-GAAP gross profit margins, and lower non-GAAP operating expenses. The higher non-GAAP gross profit margin was driven by the gain on sale of fixed assets, product cost reductions, benefits of prior year restructuring actions, product mix, and increased factory capacity utilization, partially offset by lower average pricing on mature products shipped into the mobile market.
Segment Results of Operations for the Nine Months Ended September 30, 2023 compared with the Nine Months Ended September 30, 2022
Precision Devices
(in millions)
| Nine Months Ended September 30, 2023 | Percent of Revenues | 2022 | Percent of Revenues | |
|---|---|---|---|---|
| Revenues | $151.7 | $179.6 | ||
| Earnings before interest and income taxes | $21.6 | 14.2% | $39.5 | 22.0% |
| Stock-based compensation expense | 2.8 | 2.0 | ||
| Intangibles amortization expense | 4.3 | 4.4 | ||
| Restructuring charges | 1.3 | — | ||
| Other (1) | — | 3.4 | ||
| Adjusted earnings before interest and income taxes | $30.0 | 19.8% | $49.3 | 27.4% |
| (1) 2022 expenses represent an adjustment to pre-spin-off pension obligations. |
Revenues
PD revenues were $151.7 million for the nine months ended September 30, 2023, compared with $179.6 million for the nine months ended September 30, 2022, a decrease of $27.9 million or 15.5%. Revenues decreased primarily due to lower demand from the industrial, communication, distribution, defense, and medtech markets, as a result of continued demand weakness associated with excess channel inventory and timing of shipments into the defense market.
Earnings and Adjusted Earnings Before Interest and Income Taxes
PD EBIT was $21.6 million for the nine months ended September 30, 2023, compared with $39.5 million for the nine months ended September 30, 2022, a decrease of $17.9 million. EBIT margin for the nine months ended September 30, 2023 was 14.2%, compared to 22.0% for the nine months ended September 30, 2022. The decreases were primarily due to lower revenues, lower gross profit margin, and increased operating expenses, partially offset by the absence of adjustments to pre-spin-off pension obligations in 2023. The gross profit margin decrease was primarily driven by lower factory capacity utilization, partially offset by product cost reductions and a decrease in precious metal costs.
PD Adjusted EBIT was $30.0 million for the nine months ended September 30, 2023, compared with $49.3 million for the nine months ended September 30, 2022, a decrease of $19.3 million. Adjusted EBIT margin for the nine months ended September 30, 2023 was 19.8%, compared with 27.4% for the nine months ended September 30, 2022. The decreases were primarily due to lower revenues and non-GAAP gross profit margin. The non-GAAP gross profit margin decrease was primarily driven by lower factory capacity utilization, partially offset by product cost reductions and a decrease in precious metal costs.
MedTech & Specialty Audio
(in millions)
| Nine Months Ended September 30, 2023 | Percent of Revenues | 2022 | Percent of Revenues | |
|---|---|---|---|---|
| Revenues | $162.6 | $168.1 | ||
| Earnings before interest and income taxes | $57.2 | 35.2% | $60.2 | 35.8% |
| Stock-based compensation expense | 2.6 | 2.1 | ||
| Adjusted earnings before interest and income taxes | $59.8 | 36.8% | $62.3 | 37.1% |
Revenues
MSA revenues were $162.6 million for the nine months ended September 30, 2023, compared with $168.1 million for the nine months ended September 30, 2022, a decrease of $5.5 million or 3.3%. Revenues decreased primarily due to lower shipping volumes into the hearing health market as customers reduced their inventory levels, partially offset by higher shipping volumes into the premium audio market. In addition to lower end market demand, shipping volumes were unfavorably impacted earlier this year by financial incentives offered to customers resulting in higher shipping volumes in the fourth quarter of 2022.
Earnings and Adjusted Earnings Before Interest and Income Taxes
MSA EBIT was $57.2 million for the nine months ended September 30, 2023, compared with $60.2 million for the nine months ended September 30, 2022, a decrease of $3.0 million or 5.0%. EBIT margin for the nine months ended September 30, 2023 was 35.2%, compared with 35.8% for the nine months ended September 30, 2022. The decreases were primarily due to lower revenues and higher operating expenses, partially offset by higher gross profit margin. The higher gross profit margin was driven by product cost reductions and favorable foreign currency exchange rates, partially offset by lower factory capacity utilization and product mix.
MSA Adjusted EBIT was $59.8 million for the nine months ended September 30, 2023, compared with $62.3 million for the nine months ended September 30, 2022, a decrease of $2.5 million. Adjusted EBIT margin for the nine months ended September 30, 2023 was 36.8%, compared to 37.1% for the nine months ended September 30, 2022. The decreases were primarily due to lower revenues and higher non-GAAP operating expenses, partially offset by higher non-GAAP gross profit margin. The higher non-GAAP gross profit margin was driven by product cost reductions and favorable foreign currency exchange rates, partially offset by lower factory capacity utilization and product mix.
Consumer MEMS Microphones
(in millions)
| Nine Months Ended September 30, 2023 | Percent of Revenues | 2022 | Percent of Revenues | |
|---|---|---|---|---|
| Revenues | $178.1 | $219.9 | ||
| Earnings (loss) before interest and income taxes | $9.2 | 5.2% | $(271.1) | (123.3)% |
| Stock-based compensation expense | 4.8 | 4.8 | ||
| Intangibles amortization expense | 4.5 | 4.8 | ||
| Impairment charges | — | 239.8 | ||
| Restructuring charges | (0.4) | 37.3 | ||
| Other (1) | (1.2) | 0.3 | ||
| Adjusted earnings before interest and income taxes | $16.9 | 9.5% | $15.9 | 7.2% |
| (1) Other represents the ongoing net lease cost related to facilities not used in operations. |
Revenues
CMM revenues were $178.1 million for the nine months ended September 30, 2023, compared with $219.9 million for the nine months ended September 30, 2022, a decrease of $41.8 million or 19.0%. Revenues decreased primarily due to lower demand for MEMS microphones in the mobile and IoT markets. The decreases in these markets were primarily driven by weak global demand for consumer electronics and excess inventory in the supply chain. In addition to lower end market demand, shipping volumes were unfavorably impacted earlier this year by financial incentives offered to customers resulting in higher shipping volumes in the fourth quarter of 2022. CMM revenues were also impacted by lower average pricing on mature products shipped into the mobile market.
Earnings (Loss) and Adjusted Earnings Before Interest and Income Taxes
CMM EBIT was $9.2 million for the nine months ended September 30, 2023, compared with a loss of $271.1 million for the nine months ended September 30, 2022, an improvement of $280.3 million. The increase was primarily due to impairment charges in 2022 that did not recur in 2023, higher gross margins, and lower operating expenses, partially offset by lower revenues. The higher gross profit margin was driven by lower restructuring charges, benefits of prior year restructuring actions, the gain on sale of fixed assets, product cost reductions, and favorable foreign currency exchange rates, partially offset by average pricing on mature products shipped into the mobile market and decreased factory capacity utilization.
CMM Adjusted EBIT was $16.9 million for the nine months ended September 30, 2023, compared with $15.9 million for the nine months ended September 30, 2022, an increase of $1.0 million. Adjusted EBIT margin for the nine months ended September 30, 2023 was 9.5%, compared to 7.2% for the nine months ended September 30, 2022. The increases were primarily due to higher non-GAAP gross profit margins and lower non-GAAP operating expenses, partially offset by lower revenues. The higher gross profit margin was driven by benefits of prior year restructuring actions, the gain on sale of fixed assets, product cost reductions, and favorable foreign currency exchange rates, partially offset by average pricing on mature products shipped into the mobile market and decreased factory capacity utilization.
Liquidity and Capital Resources
Historically, we have generated and expect to continue to generate positive cash flow from operations. Our ability to fund our operations and capital needs will depend on our ongoing ability to generate cash from operations and access to capital markets. We believe that our future cash flow from operations and access to capital markets will provide adequate resources to fund our working capital needs, capital expenditures, strategic investments, and share repurchases. We have secured a revolving line of credit in the United States from a syndicate of commercial banks to provide additional liquidity. Furthermore, if we were to require additional cash above and beyond our cash on the balance sheet, the free cash flow generated by the business, and availability under our revolving credit facility, we would most likely seek to raise long-term financing through the U.S. debt or bank markets.
Due to the global nature of our operations, a significant portion of our cash is generated and typically held outside the United States. Our cash and cash equivalents totaled $75.1 million and $48.2 million at September 30, 2023 and December 31, 2022, respectively. Of these amounts, cash held by our non-U.S. operations totaled $67.0 million and $40.0 million as of September 30, 2023 and December 31, 2022, respectively. To the extent we repatriate these funds to the U.S., we may be required to pay U.S. state income taxes and applicable foreign withholding taxes on those amounts during the period when such repatriation occurs. Management will continue to reassess our need to repatriate the earnings of our foreign subsidiaries.
On February 8, 2023, we entered into an Amended and Restated Credit Agreement (the "A&R Credit Agreement") that amends and restates the prior Credit Agreement (the "2020 Credit Agreement"), which provides for a senior secured revolving credit facility with borrowings in an aggregate principal amount at any time outstanding not to exceed $400.0 million. As of September 30, 2023, outstanding borrowings under the Credit Facility were $45.0 million. At any time during the term of the Credit Facility, we will be permitted to increase the commitments under the Credit Facility or to establish one or more incremental term loan facilities under the New Credit Facility in an aggregate principal amount not to exceed $200.0 million for all such incremental facilities. Commitments under the Credit Facility will terminate, and loans outstanding thereunder will mature, on February 8, 2028. For additional information, refer to Note 9. Borrowings to our Consolidated Financial Statements.
On September 25, 2023, the Company amended its A&R Credit Agreement to, among other things, (a) permit the Company in connection with the acquisition of Cornell Dubilier, to incur senior priority seller financing indebtedness (the “Seller Note”) in an aggregate principal amount of approximately $123.0 million secured by certain assets (including equity interests) acquired in connection with such acquisition and the capital stock of Knowles Intermediate PD Holdings, LLC (“Knowles PD Holdings”) (the “Acquisition Assets”), which shall mature two years after the effective date of such Seller Note (the “Seller Note Maturity Date”), (b) extends the requirement to pledge the Acquisition Assets that would otherwise constitute collateral under the Credit Agreement to the date that is 90 days after the Seller Note Maturity Date, and (c) restricts, until the Seller Note Maturity Date, the amount of dispositions and investments from the Company and certain of its subsidiaries into Knowles PD Holdings and the acquired subsidiaries that constitute Acquisition Assets from exceeding $80.0 million the aggregate. All other terms remain the same as the A&R Credit Agreement dated February 8, 2023.
On February 24, 2020, we announced that our Board of Directors had authorized a share repurchase program of up to $100 million of our common stock. On April 28, 2022, we announced that our Board of Directors had increased the authorization by up to $150 million in additional aggregate value. The timing and amount of any shares repurchased will be determined by us based on our evaluation of market conditions and other factors, and will be made in accordance with applicable securities laws in either the open market or in privately negotiated transactions. We are not obligated to purchase any shares under the program, and the program may be suspended or discontinued at any time. The actual timing, number, and share price of shares repurchased will depend on a number of factors, including the market price of our common stock, general market and economic conditions, and applicable legal requirements. Any shares repurchased will be held as treasury stock. During the nine months ended September 30, 2023 and 2022, we repurchased 1,630,161 shares and 2,339,045 shares of common stock, respectively, for a total of $27.5 million and $44.0 million, respectively.
Cash flows from operating, investing, and financing activities as reflected in our Consolidated Statements of Cash Flows are summarized in the following table:
(in millions)
| Net cash flows provided by (used in): | Nine Months Ended September 30, 2023 | 2022 |
|---|---|---|
| Operating activities | $62.3 | $39.5 |
| Investing activities | 0.3 | (25.4) |
| Financing activities | (35.3) | (40.1) |
| Effect of exchange rate changes on cash and cash equivalents | (0.4) | (1.4) |
| Net increase (decrease) in cash and cash equivalents | $26.9 | $(27.4) |
Operating Activities
Cash provided by operating activities adjusts net earnings for certain non-cash items, including impairment charges, depreciation expense, amortization of intangible assets, stock-based compensation, changes in deferred income taxes, and the effects of changes in operating assets and liabilities. The increase in cash provided by operating activities in 2023 as compared to 2022 is primarily due to an improvement in working capital and lower incentive compensation payments in 2023, partially offset by payments for previously accrued expenses, including lease and restructuring liabilities. In addition, after adjusting for non-cash expense items, net earnings were lower due primarily to an increase in professional fees. The favorable changes in working capital in 2023 were primarily driven by an increase in accounts payable and a reduction in inventories.
Investing Activities
The cash provided by investing activities during 2023 was primarily driven by proceeds from the sale of certain machinery and equipment. In addition, capital expenditures were lower in 2023 as compared to 2022. The cash used in investing activities during 2023 and 2022 was primarily driven by cash used for capital expenditures to support product innovation and cost savings.
In 2023, we expect capital expenditures to be in the range of 2% to 3% of revenues.
Financing Activities
Cash used in financing activities during 2023 was primarily related to the $27.5 million of repurchases of common stock, the $6.2 million payment of taxes related to net share settlement of equity awards, and the $1.9 million payment of debt issuance costs, partially offset by proceeds of $1.6 million from the exercise of options. Cash used in financing activities during 2022 was primarily related to the $44.0 million of repurchases of common stock and the $6.3 million payment of taxes related to net share settlement of equity awards, partially offset by net borrowings of $8.0 million under our revolving credit facility and proceeds of $6.4 million from the exercise of options.
Contingent Obligations
We are involved in various legal proceedings, claims, and investigations arising in the ordinary course of business. Legal contingencies are discussed in Note 14. Commitments and Contingent Liabilities to our Consolidated Financial Statements.
Critical Accounting Estimates
This discussion and analysis of results of operations and financial condition is based on our Consolidated Financial Statements, which have been prepared in conformity with U.S. GAAP. The preparation of these financial statements requires the use of estimates and assumptions related to the reporting of assets, liabilities, revenues, expenses, and related disclosures. In preparing these financial statements, we have made our best estimates and judgments of certain amounts included in the financial statements. Estimates are revised periodically. Actual results could differ from these estimates.
The information concerning our critical accounting estimates can be found under Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2022 filed with the Securities and Exchange Commission on February 9, 2023. There are no material changes in our previously reported critical accounting estimates.
Recent Accounting Standards
As included in Note 2. Recent Accounting Standards to our Consolidated Financial Statements, there are no recently issued or adopted accounting standards that have had or are expected to have a significant impact on our revenue, earnings, or liquidity.
Market risk
As filed, 437 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
During the nine months ended September 30, 2023, there were no material changes to the information on market risk exposure disclosed in our Annual Report on Form 10-K for the year ended December 31, 2022. For a discussion of our exposure to market risk as of December 31, 2022, refer to Item 7A, Quantitative and Qualitative Disclosures about Market Risk, contained in our Annual Report on Form 10-K for the year ended December 31, 2022.
Controls and procedures
As filed, 2,963 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
Our management has evaluated, under the supervision and with the participation of our chief executive officer ("CEO") and chief financial officer ("CFO"), the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act")) as of the end of the period covered by this report. Based on that evaluation, our CEO and CFO have concluded that, as of the end of the period covered by this report, our disclosure controls and procedures are effective in ensuring that information required to be disclosed in our Exchange Act reports is (1) recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and (2) accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting
There has been no change in our internal control over financial reporting that occurred during the third quarter of 2023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Inherent Limitations on Effectiveness of Controls
Our management, including the CEO and CFO, do not expect that our disclosure controls or our internal control over financial reporting will prevent or detect all error and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. The design of a control system must reflect the fact that the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, will be detected. These inherent limitations include the realities that judgments in decision making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by intentionally falsified documentation, by collusion of two or more individuals within Knowles or third parties, or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.
Risk factors
As filed, 183 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes from the risk factors previously disclosed under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-07-01 to 2023-09-30 | $175.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2023-01-01 to 2023-09-30 | $492.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-07-01 to 2023-09-30 | $102.7m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2023-01-01 to 2023-09-30 | $298.9m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2023-07-01 to 2023-09-30 | $77.5m | us-gaap:GrossProfit |
| Gross profit | 9 months2023-01-01 to 2023-09-30 | $205.0m | us-gaap:GrossProfit |
| Research and development | 3 months2023-07-01 to 2023-09-30 | $19.8m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2023-01-01 to 2023-09-30 | $59.5m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2023-07-01 to 2023-09-30 | $34.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2023-01-01 to 2023-09-30 | $104.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-07-01 to 2023-09-30 | $21.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2023-01-01 to 2023-09-30 | $37.5m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-07-01 to 2023-09-30 | $4.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2023-01-01 to 2023-09-30 | $9.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-07-01 to 2023-09-30 | $16.6m | us-gaap:NetIncomeLoss |
| Net income | 9 months2023-01-01 to 2023-09-30 | $25.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-07-01 to 2023-09-30 | $0.18 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2023-01-01 to 2023-09-30 | $0.27 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-07-01 to 2023-09-30 | $0.18 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2023-01-01 to 2023-09-30 | $0.27 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-07-01 to 2023-09-30 | 91,400,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2023-01-01 to 2023-09-30 | 91,900,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2023-01-01 to 2023-09-30 | $62.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2023-01-01 to 2023-09-30 | $11.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 9 months2023-01-01 to 2023-09-30 | $27.5m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-09-30 | $75.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-09-30 | $387.8m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-09-30 | $1.18bn | us-gaap:Assets |
| Current liabilities | At period end2023-09-30 | $107.0m | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2023-09-30 | $45.0m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-09-30 | $45.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2023-09-30 | $993.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001587523-23-000081. Last ingested by Listed: Nov 11, 2026, 02:23 ET. Listed shows no prices and gives no investment advice.